News
Emcutix launches Flawlizo – targeted solutions for quick acne relief: Our Bureau, Mumbai Friday, June 6, 2025, 17:10 Hrs [IST ...
Our Bureau, Mumbai Friday, June 6, 2025, 17:40 Hrs [IST] ...
Innovent Biologics presents data from phase 1 PoC study of IBI363 to treat advanced NSCLC at 2025 ASCO: San Francisco Friday, June 6, 2025, 18:00 Hrs [IST] Innovent Biologics, Inc ...
Cellectar’s IopofosineI 131 receives US FDA breakthrough therapy designation for treating Waldenstrom macroglobulinemia: Florham Park, New Jersey Friday, June 6, 2025, 17:00 Hrs ...
Leucine Rich Bio pioneers wellness revolution with microbiome-first approach: Our Bureau, Bengaluru Friday, June 6, 2025, 16:50 Hrs [IST] Leucine Rich Bio, South Asia’s dedicate ...
KPRDO vehemently opposes Karnataka Labour dept’s proposed sharp rise in minimum wages: Nandita Vijayasimha, Bengaluru Friday, ...
PCI extends timeline for registration process for ranking and rating of UG, DPharm institutes: GireeshBabu, New Delhi Friday, ...
Sarepta Therapeutics’ gene therapy to treat limb girdle muscular dystrophy type 2E/R4 gets US FDA platform technology designation: Cambridge, Massachusetts Friday, June 6, 2025, ...
Macquarie University study finds Cannabis compounds show promise in killing deadly fungal infections
Macquarie University study finds Cannabis compounds show promise in killing deadly fungal infections: Our Bureau, Bengaluru Friday, June 6, 2025, 16:40 Hrs [IST] Macquarie Univers ...
Tracky unveils India's first bluetooth-connected continuous glucose monitor for preventive healthcare: Our Bureau, Bengaluru Friday, June 6, 2025, 14:45 Hrs [IST] Tracky, a health ...
Veeva Systems & SCRI form collaboration to advance oncology clinical trials: Pleasanton, California Friday, June 6, 2025, 15:00 Hrs [IST] Veeva Systems, a global leader in cloud s ...
HIS ASEAN 2025 to make its debut in Kuala Lumpur between June 9 and 11 to discuss Southeast Asia’s medical innovation surge: Our Bureau, Mumbai Friday, June 6, 2025, 14:30 Hrs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results